Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37081465 | PubTator, text mining | PubMed |
| PRDM16 deficiency in vascular smooth muscle cells aggravates abdominal aortic aneurysm. | JCI Insight | 2023 | 37079380 | PubTator, text mining | PubMed |
| CircRNA: A new class of targets for gastric cancer drug resistance therapy. | Pathol Oncol Res | 2023 | 37065861 | PubTator, text mining | PubMed |
| NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer. | Cancer Med | 2023 | 37062069 | PubTator, text mining | PubMed |
| The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration. | Int J Mol Sci | 2023 | 37047617 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Sporadic Vestibular Schwannoma: A Systematic, Narrative Review. | Int J Mol Sci | 2023 | 37047498 | PubTator, text mining | PubMed |
| Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients: A Promising Approach to Personalized Medicine. | Int J Mol Sci | 2023 | 37047222 | PubTator, text mining | PubMed |
| High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer. | Cancers (Basel) | 2023 | 37046747 | PubTator, text mining | PubMed |
| Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37046617 | PubTator, text mining | PubMed |
| Plasma proteomic changes in response to exercise training are associated with cardiorespiratory fitness adaptations. | JCI Insight | 2023 | 37036009 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The systematic comparison between Gaussian mirror and Model-X knockoff models. | Sci Rep | 2023 | 37015993 | PubTator, text mining | PubMed |
| Regulation of human trophoblast gene expression by endogenous retroviruses. | Nat Struct Mol Biol | 2023 | 37012406 | PubTator, text mining | PubMed |
| The diverse roles of macrophages in metabolic inflammation and its resolution. | Front Cell Dev Biol | 2023 | 36994095 | PubTator, text mining | PubMed |
| REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer. | Medicina (Kaunas) | 2023 | 36984538 | PubTator, text mining | PubMed |
| MMR Deficiency Defines Distinct Molecular Subtype of Breast Cancer with Histone Proteomic Networks. | Int J Mol Sci | 2023 | 36982402 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment-A Systematic Review. | Cancers (Basel) | 2023 | 36980765 | PubTator, text mining | PubMed |
| Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer. | Curr Oncol | 2023 | 36975471 | PubTator, text mining | PubMed |
| Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma. | Blood Cancer J | 2023 | 36959208 | PubTator, text mining | PubMed |
| Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. | Front Oncol | 2023 | 36937386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=11